Related Experiment Videos
CX3CL1 and CX3CR1 expression in human brain tissue: noninflammatory control versus multiple sclerosis
Sandra Hulshof1, Elise S van Haastert, Hedwich F Kuipers
1Research Institute Neurosciences Amsterdam, VU University Medical Center, Department of Pathology, Division of Neuropathology, Amsterdam, The Netherlands. S.Hulshof@students.uu.nl
Journal of Neuropathology and Experimental Neurology
|October 10, 2003
Summary
Chemokine CX3CL1 and its receptor CX3CR1 are expressed in the human central nervous system (CNS). This study found no difference in CX3CL1 expression between controls and multiple sclerosis patients, suggesting broader physiological roles.
Area of Science:
- Neuroscience
- Immunology
Background:
- Recent studies suggest CX3CL1 plays a role in neuroinflammation and neurodegeneration.
- Understanding CX3CL1 and CX3CR1 expression in the human CNS is crucial.
Purpose of the Study:
- To compare CX3CL1 and CX3CR1 expression in human brain tissue from control and multiple sclerosis (MS) patients.
- To investigate the physiological roles of CX3CL1 and CX3CR1 in the CNS.
Main Methods:
- Human brain tissue analysis from control and MS patients.
- In vitro studies using human adult astrocyte cultures.
- Chemotaxis assays to assess microglial cell response.
Main Results:
- CX3CL1 is constitutively expressed in CNS astrocytes in vivo and in vitro.
- CX3CR1 is expressed on astrocytes and microglial cells.
- Microglial cells show a functional chemotactic response to CX3CR1 signaling.
- No significant differences in CX3CL1 expression were found between control and MS patients.
Conclusions:
- CX3CL1 exhibits constitutive expression in the human CNS, indicating general physiological functions.
- CX3CL1's role extends beyond neuroinflammation, functioning even in non-proinflammatory conditions.
- CX3CR1 signaling is functional in microglial cells within the CNS.